204 related articles for article (PubMed ID: 32487046)
21. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
23. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.
Masuda H; Brewer TM; Liu DD; Iwamoto T; Shen Y; Hsu L; Willey JS; Gonzalez-Angulo AM; Chavez-MacGregor M; Fouad TM; Woodward WA; Reuben JM; Valero V; Alvarez RH; Hortobagyi GN; Ueno NT
Ann Oncol; 2014 Feb; 25(2):384-91. PubMed ID: 24351399
[TBL] [Abstract][Full Text] [Related]
24. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status.
Shen S; Sun Q; Liang Z; Cui X; Ren X; Chen H; Zhang X; Zhou Y
PLoS One; 2014; 9(6):e100664. PubMed ID: 24945253
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
[TBL] [Abstract][Full Text] [Related]
26. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.
Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL
Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421
[TBL] [Abstract][Full Text] [Related]
27. Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
Albergaria A; Ricardo S; Milanezi F; Carneiro V; Amendoeira I; Vieira D; Cameselle-Teijeiro J; Schmitt F
BMC Cancer; 2011 Jul; 11():299. PubMed ID: 21762477
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of prognostic factors related to triple-negative breast cancer].
Shen SJ; Sun Q; Zhou YD; Guan JH; Mao F; Lin Y; Peng L; Xu Y; Wang XF; Xia W; Yao R; Han SM
Zhonghua Wai Ke Za Zhi; 2013 Nov; 51(11):1000-4. PubMed ID: 24444685
[TBL] [Abstract][Full Text] [Related]
29. Role of transforming growth factor-β1 in triple negative breast cancer patients.
Zhang M; Wu J; Mao K; Deng H; Yang Y; Zhou E; Liu J
Int J Surg; 2017 Sep; 45():72-76. PubMed ID: 28754615
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
[TBL] [Abstract][Full Text] [Related]
31. The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer.
He M; Zhang JX; Jiang YZ; Chen YL; Yang HY; Tang LC; Shao ZM; Di GH
Oncotarget; 2017 Jul; 8(27):44870-44880. PubMed ID: 28496004
[TBL] [Abstract][Full Text] [Related]
32. Impact of histotypes on preferential organ-specific metastasis in triple-negative breast cancer.
Li Y; Su P; Wang Y; Zhang H; Liang Y; Zhang N; Song X; Li X; Li J; Yang Q
Cancer Med; 2020 Feb; 9(3):872-881. PubMed ID: 31814295
[TBL] [Abstract][Full Text] [Related]
33. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
[TBL] [Abstract][Full Text] [Related]
34. Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience.
Khalifa J; Duprez-Paumier R; Filleron T; Lacroix Triki M; Jouve E; Dalenc F; Massabeau C
Breast J; 2016 Sep; 22(5):510-9. PubMed ID: 27261365
[TBL] [Abstract][Full Text] [Related]
35. Histological subtypes in triple negative breast cancer are associated with specific information on survival.
Balkenhol MCA; Vreuls W; Wauters CAP; Mol SJJ; van der Laak JAWM; Bult P
Ann Diagn Pathol; 2020 Jun; 46():151490. PubMed ID: 32179443
[TBL] [Abstract][Full Text] [Related]
36. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features of triple-negative breast cancer in Taiwanese women.
Yao-Lung K; Dar-Ren C; Tsai-Wang C
Int J Clin Oncol; 2011 Oct; 16(5):500-5. PubMed ID: 21455625
[TBL] [Abstract][Full Text] [Related]
38. Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer.
Durak MG; Gonzalez-Angulo AM; Hanrahan EO; Broglio KR; Valero V; Hortobagyi GN; Hunt KK; Sahin AA
Breast J; 2011; 17(5):462-9. PubMed ID: 21726347
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type.
Kim J; Kim JY; Lee HB; Lee YJ; Seong MK; Paik N; Park WC; Park S; Jung SP; Bae SY;
Breast Cancer Res Treat; 2020 Nov; 184(2):527-542. PubMed ID: 32794061
[TBL] [Abstract][Full Text] [Related]
40. Yes-associated protein expression in paired primary and local recurrent breast cancer and its clinical significance.
Ding N; Huang T; Yuan J; Mao J; Duan Y; Liao W; Xiao Z
Curr Probl Cancer; 2019 Oct; 43(5):429-437. PubMed ID: 30678988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
